Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Docusign Inc (DOCU) vs Procter & Gamble Co (PG) Price & Performance

Docusign IncTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Docusign Inc vs Procter & Gamble Co — how do they compare? Docusign Inc trades at $71 (market cap $12.88B), while Procter & Gamble Co trades at $150 (market cap $343.34B). The key difference: Procter & Gamble Co is far larger — about 26.7× Docusign Inc's market cap, and Procter & Gamble Co pays a 2.95% dividend while Docusign Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Docusign Inc for 71 Days and Procter & Gamble Co for 131 Days on average.

DOCUPG
Market Cap
$12.88B$343.34B
Volume
2,591,9698,662,344
Sector
TechnologyConsumer Staples
52-Week High
$73.14$167.18
52-Week Low
$41.75$138.10
Typical Hold Time
71 Days131 Days
Enterprise Value
$12.28B$369.18B
Dividend Yield
—2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Docusign Inc

DOCU trades at $71.43, up 4.71% with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The company shows robust revenue growth reaching $2.98B in 2025 with improving profit margins, though valuation ratios remain elevated. Recent news highlights AI integration in contract processing and leadership recognition in workflow software.

Outlook remains positive with projected revenue growth to $3.4B in 2026, supported by AI adoption and operating leverage. Risks include insider selling, competitive pressures, and high valuation multiples. Analyst consensus is cautious with 64% hold ratings, but technical strength and fundamental improvements suggest potential for continued upside if execution persists.

Procter & Gamble Co

Procter & Gamble (PG) trades at $150.59, up 1.47% today, with a bullish technical signal from moving averages and a consensus analyst price target of $160.13. The company reported revenue of $84.28 billion in 2025, with net income of $15.97 billion and strong profitability margins. Recent earnings have consistently beaten expectations, and the stock offers a dividend yield with a history of increases.

PG presents a stable investment with consistent earnings and dividend growth, supported by a robust balance sheet. Risks include premium valuation multiples and modest revenue growth outlook. Analyst sentiment is predominantly positive, with 53% buy ratings, but investors should monitor competitive pressures and economic sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOCU
0% Buy100% Sell
Avg holding period · 71 Days
PG
91% Buy9% Sell
Avg holding period · 131 Days

Top news

Latest headlines on both assets

About Docusign Inc

DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.

Read more on DOCU →

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG →